Philips relaunches its Azurion image-guided therapy platform, with automated 3D scanning
07 September 2020
Philips has launched the new version of its Azurion image-guided therapy platform, integrating multiple systems and tools for several minimally invasive procedures into a single footprint.
The platform links different imaging, blood flow, patient monitoring and informatics applications through a single touchscreen within the procedure room, and provides bedside control of the patient’s movable table and gantry.
“This next-generation Azurion makes routine cardiovascular procedures more efficient and supports the development of new minimally-invasive techniques to treat complex diseases such as stroke, lung cancer and spine disorders,” said Ronald Tabaksblat, general manager within Philips’ image-guided therapy systems business.
First introduced three years ago, the Azurion platform has since been used in over 2 million procedures worldwide, according to the company.
The touchscreen system also supports Philips’ new 3D imaging solution, dubbed SmartCT, which provides clinicians with step-by-step guidance for acquiring manipulable, three-dimensional images similar to a CT scan from an X-ray machine using rotational angiography.
The program also supports cone-beam CT scans for imaging soft tissue and other applications, while managing contrast injections as well.
Meanwhile, a vascular analysis system can isolate a blood vessel of interest, highlighting the path for an inserted catheter from different viewing angles for a range of neurology, oncology and cardiovascular procedures.
The SmartCT platform has not yet been cleared by the FDA and is not available in the U.S.
Published by Fierce Biotech
Image by Shutterstock